15:["$","div",null,{"style":{"minHeight":"100vh","display":"flex","flexDirection":"column"},"children":[["$","header",null,{"dangerouslySetInnerHTML":{"__html":"

$\"Molecule$

"}}],["$","main",null,{"style":{"flex":1,"maxWidth":"1200px","margin":"0 auto","width":"100%","padding":"2rem 1.5rem"},"children":[false,[["$","h1",null,{"style":{"fontFamily":"'Outfit', sans-serif","color":"#a85a30","fontSize":"2rem","fontWeight":700,"marginBottom":"2rem"},"children":"Obesity & Metabolic Health"}],["$","div",null,{"style":{"display":"grid","gridTemplateColumns":"repeat(3, 1fr)","gap":"2rem"},"children":[["$","a","cmo2vvx2k001x6p4mafuzkdsu",{"href":"/obesity-and-metabolic-health/obesity-pharmacotherapy-evolution-semaglutide-tirzepatide-retatrutide","style":{"textDecoration":"none","color":"inherit","display":"block","gap":"$undefined","padding":"1rem","borderBottom":"$undefined","border":"$undefined","borderRadius":"$undefined","boxShadow":"$undefined","marginBottom":"0","transition":"transform 0.2s"},"children":[["$","img",null,{"src":"https://pub-0704c478f1494034b5187465be51bbc3.r2.dev/sites/cmnq5qrg50001e4xw09xcflvu/2026/04/e906cf8f-a6dc-4582-9b27-b084c2362ec5-full.webp","alt":"Evolution of Obesity Pharmacotherapy with New Drugs","style":{"width":"100%","height":"200px","objectFit":"cover","borderRadius":"8px","flexShrink":0}}],["$","div",null,{"children":[["$","span",null,{"style":{"fontSize":"0.7rem","fontWeight":600,"color":"#a85a30","textTransform":"uppercase","letterSpacing":"0.05em"},"children":"Obesity & Metabolic Health"}],["$","h2",null,{"style":{"fontFamily":"'Outfit', sans-serif","color":"#a85a30","fontSize":"1.15rem","fontWeight":700,"margin":"0.25rem 0 0.5rem","lineHeight":1.3},"children":"Evolution of Obesity Pharmacotherapy with New Drugs"}],["$","p",null,{"style":{"fontSize":"0.9rem","opacity":0.75,"display":"-webkit-box","WebkitLineClamp":2,"WebkitBoxOrient":"vertical","overflow":"hidden","margin":0},"children":"Explore the fascinating evolution of obesity pharmacotherapy, from early GLP-1 therapies to the groundbreaking triple agonists like tirzepatide and retatrutide, showcasing how peptide engineering has revolutionized treatment options."}],["$","div",null,{"style":{"display":"flex","gap":"0.75rem","marginTop":"0.75rem","fontSize":"0.8rem","opacity":0.5},"children":[["$","span",null,{"children":"Admin"}],["$","span",null,{"children":"Apr 18"}],["$","span",null,{"children":[10," min"]}]]}]]}]]}]]}]],false,false]}],["$","footer",null,{"dangerouslySetInnerHTML":{"__html":"$1a"}}]]}]